IQVIA HOLDINGS INC. Investing Cash Flow
IQVIA HOLDINGS INC. (IQV) reported Investing Cash Flow of -$196.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-05-05
- IQVIA HOLDINGS INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$196.00M.
- IQVIA HOLDINGS INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$1.10B.
- IQVIA HOLDINGS INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$550.00M.
- IQVIA HOLDINGS INC. net cash provided by (used in) investing activities for the quarter ending 2025-06-30 was -$346.00M.
- IQVIA HOLDINGS INC. net cash provided by (used in) investing activities for fiscal 2025 was -$2.31B.
- IQVIA HOLDINGS INC. net cash provided by (used in) investing activities for fiscal 2024 was -$1.44B.
- IQVIA HOLDINGS INC. net cash provided by (used in) investing activities for fiscal 2023 was -$1.60B.
- IQVIA HOLDINGS INC. net cash provided by (used in) investing activities for fiscal 2022 was -$2.01B.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$196.00M 10-Q · filed 2026-05-05 | -$1.30B derived: sum of 2 quarters · filed 2026-05-05 | -$1.85B derived: sum of 3 quarters · filed 2026-05-05 | -$2.20B derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-12-31 | -$1.10B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$1.65B derived: sum of 2 quarters · filed 2026-02-17 | -$2.00B derived: sum of 3 quarters · filed 2026-02-17 | -$2.31B 10-K · filed 2026-02-17 |
| 2025-09-30 | -$550.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$896.00M derived: sum of 2 quarters · filed 2025-10-28 | -$1.20B 10-Q · filed 2025-10-28 | -$1.51B derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-06-30 | -$346.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | -$651.00M 10-Q · filed 2025-07-22 | -$961.00M derived: sum of 3 quarters · filed 2026-05-05 | -$1.56B derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-03-31 | -$305.00M 10-Q · filed 2026-05-05 | -$615.00M derived: sum of 2 quarters · filed 2026-05-05 | -$1.21B derived: sum of 3 quarters · filed 2026-05-05 | -$1.44B derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$310.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$909.00M derived: sum of 2 quarters · filed 2026-02-17 | -$1.13B derived: sum of 3 quarters · filed 2026-02-17 | -$1.44B 10-K · filed 2026-02-17 |
| 2024-09-30 | -$599.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$820.00M derived: sum of 2 quarters · filed 2025-10-28 | -$1.13B 10-Q · filed 2025-10-28 | -$1.35B derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | -$221.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | -$535.00M 10-Q · filed 2025-07-22 | -$747.00M derived: sum of 3 quarters · filed 2026-02-17 | -$1.32B derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | -$314.00M 10-Q · filed 2025-05-06 | -$526.00M derived: sum of 2 quarters · filed 2026-02-17 | -$1.10B derived: sum of 3 quarters · filed 2026-02-17 | -$1.70B derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | -$212.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$785.00M derived: sum of 2 quarters · filed 2026-02-17 | -$1.38B derived: sum of 3 quarters · filed 2026-02-17 | -$1.60B 10-K · filed 2026-02-17 |
| 2023-09-30 | -$573.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$1.17B derived: sum of 2 quarters · filed 2024-10-31 | -$1.39B 10-Q · filed 2024-10-31 | -$1.87B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | -$596.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-22 | -$818.00M 10-Q · filed 2024-07-22 | -$1.29B derived: sum of 3 quarters · filed 2025-02-13 | -$2.01B derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | -$222.00M 10-Q · filed 2024-05-02 | -$699.00M derived: sum of 2 quarters · filed 2025-02-13 | -$1.42B derived: sum of 3 quarters · filed 2025-02-13 | -$1.61B derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | -$477.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$1.19B derived: sum of 2 quarters · filed 2025-02-13 | -$1.39B derived: sum of 3 quarters · filed 2025-02-13 | -$2.01B 10-K · filed 2025-02-13 |
| 2022-09-30 | -$717.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$916.00M derived: sum of 2 quarters · filed 2023-11-01 | -$1.53B 10-Q · filed 2023-11-01 | -$2.18B derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | -$199.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$812.00M 10-Q · filed 2023-08-01 | -$1.46B derived: sum of 3 quarters · filed 2024-02-15 | -$2.55B derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | -$613.00M 10-Q · filed 2023-04-28 | -$1.26B derived: sum of 2 quarters · filed 2024-02-15 | -$2.35B derived: sum of 3 quarters · filed 2024-02-15 | -$2.54B derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | -$647.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | -$1.74B derived: sum of 2 quarters · filed 2024-02-15 | -$1.93B derived: sum of 3 quarters · filed 2024-02-15 | -$2.10B 10-K · filed 2024-02-15 |
| 2021-09-30 | -$1.09B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$1.28B derived: sum of 2 quarters · filed 2022-10-27 | -$1.46B 10-Q · filed 2022-10-27 | -$1.69B derived: sum of 4 quarters · filed 2023-02-15 |
| 2021-06-30 | -$185.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22 | -$361.00M 10-Q · filed 2022-07-22 | -$597.00M derived: sum of 3 quarters · filed 2023-02-15 | -$788.00M derived: sum of 4 quarters · filed 2023-02-15 |
| 2021-03-31 | -$176.00M 10-Q · filed 2022-04-28 | -$412.00M derived: sum of 2 quarters · filed 2023-02-15 | -$603.00M derived: sum of 3 quarters · filed 2023-02-15 | -$822.00M derived: sum of 4 quarters · filed 2023-02-15 |
| 2020-12-31 | -$236.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | -$427.00M derived: sum of 2 quarters · filed 2023-02-15 | -$646.00M derived: sum of 3 quarters · filed 2023-02-15 | -$796.00M 10-K · filed 2023-02-15 |
| 2020-09-30 | -$191.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-22 | -$410.00M derived: sum of 2 quarters · filed 2021-10-22 | -$560.00M 10-Q · filed 2021-10-22 | -$840.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | -$219.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | -$369.00M 10-Q · filed 2021-07-28 | -$649.00M derived: sum of 3 quarters · filed 2022-02-16 | -$1.05B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | -$150.00M 10-Q · filed 2021-04-23 | -$430.00M derived: sum of 2 quarters · filed 2022-02-16 | -$830.00M derived: sum of 3 quarters · filed 2022-02-16 | -$1.02B derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | -$280.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$680.00M derived: sum of 2 quarters · filed 2022-02-16 | -$875.00M derived: sum of 3 quarters · filed 2022-02-16 | -$1.19B 10-K · filed 2022-02-16 |
| 2019-09-30 | -$400.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-22 | -$595.00M derived: sum of 2 quarters · filed 2020-10-22 | -$910.00M 10-Q · filed 2020-10-22 | -$1.09B derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | -$195.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-23 | -$510.00M 10-Q · filed 2020-07-23 | -$688.00M derived: sum of 3 quarters · filed 2021-02-12 | -$870.00M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | -$315.00M 10-Q · filed 2020-04-30 | -$493.00M derived: sum of 2 quarters · filed 2021-02-12 | -$675.00M derived: sum of 3 quarters · filed 2021-02-12 | -$1.00B derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | -$178.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | -$360.00M derived: sum of 2 quarters · filed 2021-02-12 | -$690.00M derived: sum of 3 quarters · filed 2021-02-12 | -$810.00M 10-K · filed 2021-02-12 |
| 2018-09-30 | -$182.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | -$512.00M derived: sum of 2 quarters · filed 2019-11-01 | -$632.00M 10-Q · filed 2019-11-01 | -$1.05B derived: sum of 4 quarters · filed 2020-02-18 |
| 2018-06-30 | -$330.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | -$450.00M 10-Q · filed 2019-07-24 | -$866.00M derived: sum of 3 quarters · filed 2020-02-18 | -$1.20B derived: sum of 4 quarters · filed 2020-02-18 |
| 2018-03-31 | -$120.00M 10-Q · filed 2019-05-02 | -$536.00M derived: sum of 2 quarters · filed 2020-02-18 | -$870.00M derived: sum of 3 quarters · filed 2020-02-18 | |
| 2017-12-31 | -$416.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | -$750.00M derived: sum of 2 quarters · filed 2020-02-18 | -$1.19B 10-K · filed 2020-02-18 | |
| 2017-09-30 | -$334.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | -$774.00M 10-Q · filed 2018-10-25 | ||
| 2017-06-30 | -$440.00M 10-Q · filed 2018-07-27 | |||
| 2016-12-31 | $1.73B 10-K · filed 2019-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |